Kevin Koch, President and CEO of Edgewise Therapeutics ($EWTX), made two open market sales of company shares over the past year, totaling about $177,000. His most recent sale occurred on August 12, 2025. These transactions rank 8,690th among 11,678 insiders by sale value, well below the average of $8.6 million per seller and 6.4 sales. Koch reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Common Stock | 17968 | $0.00 | 377,371.0000 | 104,940,493 | 5.00% | 0.02% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | S | Common Stock | 7972 | $13.39 | 369,399.0000 | 104,940,493 | 2.11% | 0.01% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Restricted Stock Units | 17968 | $0.00 | 53,907.0000 | 104,940,493 | 25.00% | 0.02% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | A | Restricted Stock Units | 87500 | $0.00 | 87,500.0000 | 104,940,493 | 9999.99% | 0.08% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | A | Stock Option (Right to Buy) | 525000 | $0.00 | 525,000.0000 | 104,940,493 | 9999.99% | 0.50% |
| May 1, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Common Stock | 10417 | $0.00 | 390,089.0000 | 95,130,053 | 2.74% | 0.01% |
| May 2, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | S | Common Stock | 4276 | $16.45 | 385,813.0000 | 95,130,053 | 1.10% | 0.00% |
| May 1, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Restricted Stock Units | 10417 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| March 7, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Common Stock | 100 | $0.18 | 353,362.0000 | 92,414,626 | 0.03% | 0.00% |
| March 7, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | S | Common Stock | 100 | $30.00 | 353,262.0000 | 92,414,626 | 0.03% | 0.00% |
| March 7, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Stock Option (Right to Buy) | 100 | $0.00 | 41,545.0000 | 92,414,626 | 0.24% | 0.00% |
| Feb. 5, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Common Stock | 8636 | $0.18 | 361,898.0000 | 92,414,626 | 2.44% | 0.01% |
| Feb. 5, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | S | Common Stock | 8636 | $30.03 | 353,262.0000 | 92,414,626 | 2.39% | 0.01% |
| Feb. 6, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Common Stock | 900 | $13.11 | 354,162.0000 | 92,414,626 | 0.25% | 0.00% |
| Feb. 6, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | S | Common Stock | 900 | $31.13 | 353,262.0000 | 92,414,626 | 0.25% | 0.00% |
| Feb. 5, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Stock Option (Right to Buy) | 8636 | $0.00 | 42,545.0000 | 92,414,626 | 16.87% | 0.01% |
| Feb. 6, 2025 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Stock Option (Right to Buy) | 900 | $0.00 | 41,645.0000 | 92,414,626 | 2.12% | 0.00% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | A | Stock Option (Right to Buy) | 431250 | $0.00 | 431,250.0000 | 93,515,356 | 9999.99% | 0.46% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | A | Restricted Stock Units | 71875 | $0.00 | 71,875.0000 | 93,515,356 | 9999.99% | 0.08% |
| May 1, 2024 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Common Stock | 10417 | $0.00 | 356,414.0000 | 87,567,307 | 3.01% | 0.01% |
| May 2, 2024 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | S | Common Stock | 3152 | $18.91 | 353,262.0000 | 87,567,307 | 0.88% | 0.00% |
| May 1, 2024 | Edgewise Therapeutics, Inc. | $EWTX | KOCH KEVIN | President and CEO | M | Restricted Stock Units | 10417 | $0.00 | 10,417.0000 | 87,567,307 | 50.00% | 0.01% |